Overview

STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)

Status:
Terminated

Trial end date:
2021-03-12

Target enrollment:

Participant gender:

Summary

To determine whether the combination of gemcitabine/carboplatin with hydroxychloroquine (HCQ) is associated with an improved clinical outcome (progression free and overall survival) compared with chemotherapy alone in patients with small cell lung cancer (SCLC)

Phase:

Phase 2

Details

Lead Sponsor:

University College, London

Treatments:

Carboplatin
Etoposide
Etoposide phosphate
Gemcitabine
Hydroxychloroquine